(Q39091664)
Statements
1 reference
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial (English)
1 reference
Kenneth W Mahaffey
1 reference
Matthew T Roe
1 reference
Robert A Harrington
1 reference
Pierluigi Tricoci
1 reference
Andreas Zeiher
1 reference
Deepak L Bhatt
1 reference
J Wouter Jukema
1 reference
Harvey White
1 reference
Lisa G Berdan
1 reference
Shaun G Goodman
1 reference
Tyrus Rorick
1 reference
Vera Bittner
1 reference
Corinne Hanotin
1 reference
Angèle Moryusef
1 reference
Robert Pordy
1 reference
William J Sasiela
1 reference
Jean-François Tamby
1 reference
Gregory G Schwartz
1 reference
Laurence Bessac
1 reference
Rafael Diaz
1 reference
Cheerag Shirodaria
1 reference
Michael Szarek
1 reference
7 August 2014
1 reference
1 reference
168
1 reference
5
1 reference
682-689
1 reference
Identifiers
1 reference
1 reference